Advances and future directions for mechanical circulatory support

Anesthesiology Clinics

Volumn 31, Issue 2, 2013, Pages 321-353

  Capdeville, Michelle ^a   Smedira, Nicholas G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Axial flow; Heart mate II; HeartWare; Mechanical circulatory support; Ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; CLENBUTEROL; HEPARIN; LISINOPRIL; LOSARTAN; SPIRONOLACTONE; WARFARIN;

ANTICOAGULANT THERAPY; ASSISTED CIRCULATION; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BLOOD FLOW; DEVICE INFECTION; DEVICE THERAPY; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMOLYSIS; HUMAN; HYPOVOLEMIA; HYPOXEMIA; IDIOPATHIC DISEASE; IMPLANTABLE PUMP; IMPLANTATION; INFECTION RATE; LEFT VENTRICULAR ASSIST DEVICE; LUNG EMBOLISM; MECHANICAL CIRCULATORY SUPPORT; MORBIDITY; MULTICENTER STUDY (TOPIC); NONISCHEMIC CARDIOMYOPATHY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; REVIEW; RISK ASSESSMENT; SEPSIS; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL; THROMBUS; TRANSIENT ISCHEMIC ATTACK; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ANESTHESIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; RISK ASSESSMENT;

EID: 84878650940     PISSN: 19322275     EISSN: 22103538     Source Type: Journal    
DOI: 10.1016/j.anclin.2012.12.003     Document Type: Review

References (112)

1. Reich D.J., Mulligan D.C., Abt P.L., et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009, 9:2004-2011.
2. Ali A.A., White P., Xiang B., et al. Hearts from DCD donors display acceptable biventricular function after heart transplantation in pigs. Am J Transplant 2011, 11:1621-1632.
3. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010, 29:1089-1103.
4. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
5. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241-2251.
6. Lietz K., Deng M., Morgan J., et al. Selection of UNOS status 1A candidates for mechanical circulatory support as bridge-to-transplantation (BTT)-Analysis of UNOS/OPTN 2000-2005. J Heart Lung Transplant 2008, 27(2S):S244.
7. Zimpfer D., Zrunek P., Roethy W., et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007, 133:689-695.
8. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic ventricular unloading. Ann Thorac Surg 1996, 62:675-681.
9. Dandel M., Weng Y., Siniawski H., et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005, 112(Suppl I):I37-I45.
10. Simon M.A., Kormos R.L., Murali S., et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005, 112:I32-I36.
11. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998, 98:2383-2389.
12. Klotz S., Danser A.H., Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008, 97:479-496.
13. Maybaum S., Mancini D., Xydas S., et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007, 115:2497-2505.
14. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006, 355:1873-1884.
15. George R.S., Yacoub M.H., Bowles C.T., et al. Quality of life after removal of left ventricular assist device for myocardial recovery. J Heart Lung Transplant 2008, 27:165-172.
16. Birks E.J., George R.S., Hedger M., et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011, 123:381-390.
17. Wong K., Boheler K., Petrou M., et al. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix and gene expression. Circulation 1997, 96:2239-2246.
18. Wong K., Boheler K.R., Bishop J., et al. Clenbuterol induces cardiac hypertrophy with normal functional, morphological, and molecular features. Cardiovasc Res 1998, 37:115-122.
19. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007, 116:497-505.
20. Higgins J., Lamarche Y., Kaan A., et al. Microaxial devices for ventricular failure: a multicentre, population-based experience. Can J Cardiol 2011, 27:725-730.
21. Bruckner B.A., Jacob L.P., Gregoric I.D., et al. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J 2008, 35:447-450.
22. Marasco S.F., Lukas G., McDonald M., et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 2008, 17(Suppl 4):S41-S47.
23. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005, 129:9-17.
24. Rogers J.G., Butler J., Lansman S.L., et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007, 50:741-747.
25. Holman W.L., Pae W.E., Teuteberg J.J., et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009, 208:755-761.
26. Kirklin J.K., Naftel D.C., Kormos R.L., et al. The fourth INTERMACS annual report: 4000 implants and counting. J Heart Lung Transplant 2012, 31:117-126.
27. Stevenson L.W., Pagani F.D., Young J.B., et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009, 28:535-541.
28. Lietz K., Miller L.W. Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009, 24:246-251.
29. Alba A.C., Rao V., Ivanov J., et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009, 28:827-833.
30. Teuteberg J.J., Ewald G.A., Adamson R.M., et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1000 patients. J Am Coll Cardiol 2012, 60:44-51.
31. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score: a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51:2163-2172.
32. Potapov E.V., Loebe M., Nasseri B.A., et al. Pulsatile flow in patients with a novel non-pulsatile implantable ventricular assist device. Circulation 2000, 102(19 Suppl 3):III183-III187.
33. John R. Current axial-flow devices: the HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg 2008, 20:264-272.
34. Thalmann M., Schima H., Wieselthaler G., et al. Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 2005, 24:237-245.
35. OOtaki C., Yamashita M., OOtaki Y., et al. Reduced pulsatility induces periarteritis in kidney: role of local renin-angiotensin system. J Thorac Cardiovasc Surg 2008, 136:150-158.
36. Nishimura T., Tatsumi E., Takaichi S., et al. Prolonged nonpulsatile left heart bypass with reduced systemic pulse pressure causes morphological changes in the aortic wall. Artif Organs 1998, 22:405-410.
37. Kihara S., Litwak K.N., Nichols L., et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 2003, 75:178-183.
38. Frazier O.H., Myers T.J., Westaby S., et al. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg 2003, 237:631-636.
39. Mudd J.O., Cuda J.D., Halushka M., et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant 2008, 27:1269-1274.
40. Tominaga R., Smith W.A., Massiello A., et al. Chronic non-pulsatile blood flow. I. Cerebral autoregulation in chronic nonpulsatile biventricular bypass: carotid blood flow response to hypercapnia. J Thorac Cardiovasc Surg 1994, 108:907-912.
41. Letsou G.V., Shah N., Gregoric I.D., et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial flow left ventricular assist device. J Heart Lung Transplant 2005, 24:105-109.
42. Stern D.R., Kazam J., Edwards P., et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010, 25:352-356.
43. Pate G.E., Mulligan A. An epidemiological study of Heyde's syndrome: an association between aortic stenosis and gastrointestinal bleeding. J Heart Valve Dis 2004, 13:713-716.
44. Heyde E.C. Gastrointestinal bleeding in aortic stenosis. N Engl J Med 1958, 259:196. [Letter to the editor].
45. Singh P., Scoyni R., Pooran N., et al. Aortic valve replacement: a last resort for aortic stenosis-associated refractory GI bleeding. Gastrointest Endosc 2002, 56:139-141.
46. Warkentin T.E., Moore J.C., Morgan D.G. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?. Lancet 1992, 340:35-37.
47. Vincentelli A., Susen S., Le Tourneau T., et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003, 349:343-349.
48. Geisen U., Heilmann C., Beyersdorf F., et al. Nonsurgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008, 33:679-684.
49. Klovaite J., Gustafsson F., Mortensen S.A., et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009, 53:2162-2167.
50. Cappell M.S., Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Ann Intern Med 1986, 105:54-57.
51. Meyer A.L., Malehsa D., Bara C., et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010, 3:675-681.
52. Boyle A.J., Russell S.D., Teuteberg J.J., et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009, 28:881-887.
53. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885-896.
54. Griffith B.P., Kormos R.L., Borovetz H.S., et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001, 71(Suppl 3):S116-S120.
55. Khalil H.A., Cohn W.E., Metcalfe R.W., et al. Preload sensitivity of the Jarvik 2000 and HeartMate II left ventricular assist devices. ASAIO J 2008, 54:245-248.
56. Mano A., Fujita K., Uenomachi K., et al. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 2009, 28:428-433.
57. Holdy K., Dembitsky W., Eaton L.L., et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 2005, 24:1690-1696.
58. Farrar D.J., Compton P.G., Hershon J.J., et al. Right heart interaction with the mechanically assisted left heart. World J Surg 1985, 9:89-102.
59. Santamore W.P., Gray L.A. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996, 61:350-356.
60. Patel N.D., Weiss E.S., Schaffer J., et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008, 86:832-840.
61. Kormos R.L., Teuteberg J.J., Pagani F.D., et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010, 139:1316-1324.
62. Sandner S.E., Zimpfer D., Zrunek P., et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009, 87:1072-1078.
63. Kormos R.L., Teuteberg J.J., Siegenthaler M.P., et al. Pre-VAD implant risk factors influence the onset of adverse events (AEs) while on VAD. J Heart Lung Transplant 2009, 28:S153-S154. [abstract].
64. Feussner M., Mukherjee C., Garbade J., et al. Anaesthesia for patients undergoing ventricular assist-device implantation. Best Pract Res Clin Anaesthesiol 2012, 26:167-177.
65. Nussmeier N.A., Probert C.B., Hirsch D., et al. Anesthetic management for implantation of the Jarvik 2000 left ventricular assist system. Anesth Analg 2003, 97:964-971.
66. Broussard D., Donaldson E., Falterman J., et al. Anesthesia for left ventricular assist device insertion: a case series and review. Ochsner J 2011, 11:70-77.
67. Stone M.E. Current status of mechanical circulatory assistance. Semin Cardiothorac Vasc Anesth 2007, 11:185-204.
68. Thinberg C.A., Gaitan B.D., Arabia F.A., et al. Ventricular assist devices today and tomorrow. J Cardiothorac Vasc Anesth 2010, 24:656-680.
69. Kavarana M.N., Pessin-Minsley M.S., Urtecho J., et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002, 73:745-750.
70. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third Annual Report-2005. J Heart Lung Transplant 2005, 24:1182-1187.
71. Dang N.C., Topkara V.K., Mercando M., et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006, 25:1-6.
72. Fukamachi K., McCarthy P.M., Smedira N.G., et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999, 68:2181-2184.
73. Kormos R.L., Gasior T.A., Kawai A., et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996, 111:773-782.
74. Ochiai Y., McCarthy P.M., Smedira N.G., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002, 106(12 Suppl I):I198-I202.
75. Nakatani A., Thomas J.D., Savage R.M., et al. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation 1996, 94(Suppl 9):II216-II221.
76. De Wet C.J., Affleck D.G., Jacobsohn E., et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004, 127:1058-1067.
77. Oz M.C., Argenziano M., Catanese K.A., et al. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation?. Circulation 1997, 95:1844-1852.
78. Salzberg S.P., Lachat M.L., Zund G., et al. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg 2004, 26:444-446.
79. Argenziano M., Choudhri A.F., Oz M.C., et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997, 96(Suppl 9):II286-II290.
80. Maslow A.D., Stearns G., Butala P., et al. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 2006, 103:2-8.
81. Potapov E.V., Pasic M., Bauer M., et al. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 2002, 74:2182-2183.
82. Heise D., Brauer A., Quintel M. Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: case report and review of the current literature. J Cardiothorac Surg 2007, 2:47.
83. Bruckner B.A., DiBardino D.J., Ning Q., et al. High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII. J Heart Lung Transplant 2009, 28:785-790.
84. Banchis J.E., Dawn B., Abdel-Latif A., et al. Acquired aortic cusp fusion after chronic left ventricular assist device support. J Am Soc Echocardiogr 2006, 19:1401.e1-1401.e3.
85. Haghi D., Suselbeck T., Saur J. Aortic regurgitation during left ventricular assist device support. J Heart Lung Transplant 2007, 26:1220-1221.
86. Park S.J., Liao K.K., Segurola R., et al. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Thorac Cardiovasc Surg 2004, 127:264-266.
87. Stringham J.C., Bull D.A., Karwande S.V. Patch closure of the aortic anulus in a recipient of a ventricular assist device. J Thorac Cardiovasc Surg 2000, 119:1293-1294.
88. Marriott K, Manins V, Forshaw A, et al. Detection of right-to-left atrial communication using agitated saline contrast imaging: experience with 1162 patients and recommendations for echocardiography. J Am Soc Echocardiogr. Available at: Accessed October, 2012. http://dx.doi.org/10.1016/j.echo.2012.09.007.
89. Lynch J.J., Schuchard G.H., Gross C.M., et al. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol 1984, 53:1478-1480.
90. Scalia G.M., McCarthy P.M., Savage R.M., et al. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr 2000, 13:754-763.
91. Catena E., Milazzo F., Merli M., et al. Echocardiographic evaluation of patients receiving a new left ventricular assist device: the Impella® Recover 100. Eur J Echocardiogr 2004, 5:430-437.
92. May-Newman K.D., Hillen B.K., Sironda C.S., et al. Effect of LVAD outflow conduit insertion angle on flow through the native aorta. J Med Eng Technol 2004, 28:105-109.
93. Topilsky Y., Maltais S., Oh J.K., et al. Focused review on transthoracic echocardiographic assessment of patients with continuous axial flow left ventricular assist devices. Cardiol Res Pract 2011, 2011:187434.
94. Slaughter M.S., Pagani F.D., Rogers J.G., et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010, 29(Suppl 4):S1-S39.
95. Maniar S., Kondareddy S., Topkara V.K. Left ventricular assist device-related infections: past, present, and future. Expert Rev Med Devices 2011, 8:627-634.
96. Ankersmit H.J., Edwards N.M., Schuster M., et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 1999, 100(Suppl 19):II211-II215.
97. Aaronson K.D., Slaughter M.S., Miller L.W., et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012, 125:3191-3200.
98. Catena E., Milazzo F., Montorsi E., et al. Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction. J Am Soc Echocardiogr 2005, 18:1422.e7-1422.e13.
99. Estep J.D., Stainback R.F., Little S.H., et al. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. J Am Coll Cardiol 2010, 3:1049-1064.
100. Hoshi H., Shinshi T., Takatani S. Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs 2006, 30:324-338.
101. Farrar D.J., Bourque K., Dague C.P., et al. Design features, developmental status, and experimental results with the HeartMate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J 2007, 53:310-315.
102. Nojiri C., Kijima T., Maekawa J., et al. Development status of Terumo implantable left ventricular assist system. Artif Organs 2001, 25:411-413.
103. Morshuis M., El-Banayosy A., Arusoglu L., et al. European experience with DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009, 35:1020-1027.
104. Slaughter M.S., Sobieski M.A., Tamez D., et al. HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test. Tex Heart Inst J 2009, 36:12-16.
105. Tuzun E., Roberts K., Cohn W.E., et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007, 34:406-411.
106. LaRose J., Tamez D., Ashenuga M., et al. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 2010, 56:285-289.
107. Strueber M., O'Driscoll G., Jansz P., et al. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011, 57:1375-1382.
108. Wieselthaler G.M., O'Driscoll G., Jansz P., et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010, 29:1218-1225.
109. Hetzer R., Krabatsch T., Stepanenko A., et al. Long-term biventricular support with the HeartWare implantable continuous flow pump. J Heart Lung Transplant 2010, 29:822-824.
110. Aaronson K.D., Slaughter M.S., McGee E., et al. Evaluation of the HeartWare® HVAD left ventricular assist system for the treatment of advanced heart failure: results of the ADVANCE Bridge to Transplant Trial. Circulation 2010, 122:2215-2226. [abstract].
111. Kirklin J.K., Naftel D.C., Pagani F.D., et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?. J Thorac Cardiovasc Surg 2012, 144:584-603.
112. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 2011, 30:1078-1094.